Navigation Links
CUREXO Technology Corporation Announces New Headquarters
Date:3/2/2009

SACRAMENTO, Calif., March 2 /PRNewswire/ -- CUREXO Technology Corporation, pioneer in medical robotics and world leader in image-directed robotic products for orthopaedic applications, which is focused on marketing its ROBODOC(R) Surgical System, announced today that it would be relocating its headquarters from Sacramento to Fremont and has already begun the transition with the corporate executives; the remainder of the company will be in place by April 2009.

CUREXO Technology Corporation's new headquarters will be approximately 34,000 square feet which is more than 3 times the size of its current facility in Sacramento. This new location in the Silicon Valley provides excellent access to multiple international airports increasing headquarter accessibility to visitors. Fremont is located in the San Francisco East Bay area, just 15 miles from San Jose and 30 miles from Oakland.

"We are excited about moving the company to our new home," stated Brent D. Mittelstadt, President and CEO of CUREXO Technology Corporation. "The size of the new facility will allow CUREXO to fully embark on its U.S. launch and worldwide marketing strategy as it will provide ample space to manufacture our robotic system at a higher rate. As well, the location is strategic, as we will be physically closer to our vendors and we will be able to draw from a pool of highly accomplished professionals from the Silicon Valley that will complement our existing team of talented personnel," continued Mr. Mittelstadt.

About CUREXO Technology Corporation

CUREXO Technology Corporation develops, manufactures, and markets an image directed surgical robotic system for orthopaedic surgery. The ROBODOC(R) Surgical System includes two components; ORTHODOC(R), a computer workstation equipped with proprietary software for 3-D preoperative surgical planning, and the ROBODOC(R) Surgical Assistant, a computer-controlled surgical robot utilized for precise cavity and surface preparation for hip and knee replacement surgeries.

The ROBODOC(R) Surgical System has been cleared by the U.S. FDA for Total Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic surgery. To date the system has been used in over 24,000 surgical procedures worldwide.

ROBODOC(R) and ORTHODOC(R) are registered trademarks of CUREXO Technology Corporation. For more information, visit www.robodoc.com.

    Contact:
    Ms. Sheila Shah
    Marketing Communications
    CUREXO Technology Corporation
    916 285 9943 X 510
    press@robodoc.com


'/>"/>
SOURCE CUREXO Technology Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
2. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
3. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
4. Novel Technology Breaks Through Cancer Pain
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. Advanced Cell Technology Announces Proposed Financing
7. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
11. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan 19, 2017 Research and ... by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis ... ... forecasts that the global market is projected to reach $15,737 million ... 13% from 2016 to 2022. Omic technologies segment ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the "Implantable Biomaterials ... report to their offering. Report Highlights: ... detailed analysis on current and future market trends to identify the investment ... as the base numbers Key market trends across the ...
(Date:1/19/2017)... CALABASAS, Calif. , Jan. 19, 2017 /PRNewswire/ ... Mathias Schmidt , Ph.D., as chief executive ... board of directors. Dr. Schmidt brings to ArmaGen more ... on the research and development of biotherapeutics and ... biopharmaceutical executive with the diverse experience and skillset ...
(Date:1/19/2017)... Staten Island, NY (PRWEB) , ... January 19, 2017 , ... ... expand at an exponential rate. The tremendous growth is accounted to two main ... to the table and the expanding network of vendors supplying FireflySci products all around ...
Breaking Biology Technology:
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
Breaking Biology News(10 mins):